Remdesivir is proven to reverse, stop, or cure COVID-19 in initial trials. However, the number of people treated is not sufficient to draw a conclusion on how well the drug will work generally. Remdesivir kills the COVID-19 virus, SARS-CoV-2 (novel coronavirus) by stopping replication of the virus. Remdesivir is a broad-spectrum antiviral agent. It was developed as a treatment for Ebola virus infection. It causes a decrease in viral RNA production, thus limiting replication and proliferation of the infection. Initial results from three U.S. COVID-19 patients who were treated with Remdesivir outside of a clinical trial are not uniformly successful. Here is information about a case study presented by Dr. Lewis. According to MYNorthwest News, “His dad was sick at home for a few days before his oxygen levels dropped, forcing him to go to the hospital, where he tested positive for coronavirus. He was also suffering from pneumonia. His doctor gave his father Remdesivir, a drug originally intended to treat Ebola that’s seen some success in a handful of isolated coronavirus cases. The treatment dropped his fever quickly and he steadily improved. Now, nine days after going to the emergency room, his dad is going home.